|
ATP6V0A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.136800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.984600E-01 |
| Normal-vs-Stage2 |
4.809000E-01 |
| Normal-vs-Stage3 |
2.319400E-01 |
| Normal-vs-Stage4 |
4.624800E-01 |
| Stage1-vs-Stage2 |
4.551400E-01 |
| Stage1-vs-Stage3 |
1.162390E-01 |
| Stage1-vs-Stage4 |
4.323200E-01 |
| Stage2-vs-Stage3 |
7.671400E-01 |
| Stage2-vs-Stage4 |
9.874000E-01 |
| Stage3-vs-Stage4 |
7.775400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.363400E-01 |
| Normal-vs-AfricanAmerican |
3.035600E-01 |
| Normal-vs-Asian |
5.253600E-02 |
| Caucasian-vs-AfricanAmerican |
2.585000E-01 |
| Caucasian-vs-Asian |
2.929900E-02 |
| AfricanAmerican-vs-Asian |
1.523880E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.122000E-01 |
| Normal-vs-Female |
7.675200E-01 |
| Male-vs-Female |
4.039000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.238000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.083800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.407200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.440200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.178190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.410000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.278200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.219400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.613200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.848600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.878400E-01 |
| Classical-VS-Follicular |
5.388000E-04 |
| Classical-VS-Other |
1.071390E-01 |
| Classical-VS-Normal |
5.922200E-01 |
| Tall-VS-Follicular |
9.125800E-02 |
| Tall-VS-Other |
1.263550E-01 |
| Tall-VS-Normal |
7.941400E-01 |
| Follicular-VS-Other |
7.093200E-01 |
| Follicular-VS-Normal |
3.496000E-02 |
| Other-VS-Normal |
1.103390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.894580E-01 |
| Normal-vs-N1 |
3.655800E-01 |
| N0-vs-N1 |
9.715600E-01 |
|
|
